Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02492100 · ClinicalTrials.gov registry record · NA
A Multimodal Intervention to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant Survivors
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT02492100: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02492100 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02492100, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
This research study is evaluating the feasibility and impact of an intervention to improve sexual function in stem cell transplant survivors on participants' sexual function, quality of life, and mood. \- It is expected that about 50 stem cell transplant survivors will take part in this research study.
Interventions
- BEHAVIORAL Multi-modality sexual dysfunction intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02492100
The ClinicalTrials.gov registry entry for NCT02492100 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Multi-modality sexual dysfunction intervention is the first listed.
NCT02492100 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02492100 about?
NCT02492100 is a clinical study titled "A Multimodal Intervention to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant Survivors". This research study is evaluating the feasibility and impact of an intervention to improve sexual function in stem cell transplant survivors on participants' sexual function, quality of life, and mood. \- It is expected that about 50 stem cell transplant survivors will take part in this research st...
What is the current status of trial NCT02492100?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2015-06. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02492100?
The interventions under investigation include: Multi-modality sexual dysfunction intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02492100?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.